Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01901510 · ClinicalTrials.gov registry record · Phase 1
Panchromoendoscopy Using Oral Indigo Carmine Mixed With Polyethylene Glycol Prep
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT01901510: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT01901510 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01901510, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study first is designed to see what dose of indigo carmine ingested orally mixed with the standard colonoscopy prep is needed to provide adequate staining of the right colon. It then will use this adequate staining concentration of Indigo Carmine to study whether this dye will increase the detection of polyps during colonoscopy.
Interventions
- OTHER Control
- DRUG Chromoendoscopy (Indigo Carmine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-05 |
| Est. Completion | 2014-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01901510
The ClinicalTrials.gov registry entry for NCT01901510 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT01901510 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01901510 about?
NCT01901510 is a clinical study titled "Panchromoendoscopy Using Oral Indigo Carmine Mixed With Polyethylene Glycol Prep". This study first is designed to see what dose of indigo carmine ingested orally mixed with the standard colonoscopy prep is needed to provide adequate staining of the right colon. It then will use this adequate staining concentration of Indigo Carmine to study whether this dye will increase the dete...
What is the current status of trial NCT01901510?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2013-05. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01901510?
The interventions under investigation include: Control (OTHER), Chromoendoscopy (Indigo Carmine) (DRUG).
Who is sponsoring clinical trial NCT01901510?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.